Market Overview:
The global HIV point-of-care testing market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of HIV/AIDS, growing demand for rapid and accurate diagnosis, and technological advancements in point-of-care testing devices. The global HIV point-of-care testing market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into testing equipment and testing reagents. The equipment segment is further subsegmented into lateral flow assay devices, immunoassay analyzers, molecular diagnostic systems & consumables), while the reagent segment is further subsegmented into ELISA kits & strips). On the basis of application,the marketis dividedinto hospitals clinics,, home care setting)andregion (North America,, Europe Asia Pacificand Middle East Africa).
Product Definition:
Point-of-care HIV testing is a type of HIV test that can be performed in a doctor's office, clinic, or other healthcare setting. This type of test allows for the collection of a blood sample or oral fluid specimen for HIV testing on the spot. Results are typically available within minutes. Point-of-care HIV tests are used to diagnose HIV infection and to monitor the effectiveness of antiretroviral therapy.
Testing Equipment:
Testing equipment is used by healthcare professionals to diagnose and treat patients. It includes a wide range of devices such as clinical chemistry analyzers, hematology instruments, coagulation instruments, urine analyzers & pregnancy tests among others. HIV point-of-care testing market is one of the fastest growing segments in this industry owing to factors such as increasing prevalence rate of HIV and other associated infections along with rising government initiatives for creating awareness about self diagnosis using portable devices at the primary care level.
Testing Reagent:
Testing reagent is a consumable medical device or kit used by healthcare professionals for the detection of diseases and other health conditions. It helps in detecting various infectious diseases such as HIV, HCV, & others. The testing reagents are available in different forms such as liquids, drops, powders & solutions and are used on the basis of disease diagnosis.
Application Insights:
The market is segmented on the basis of application into hospitals, clinics and home care settings. The hospital segment dominated the overall HIV point-of-care testing market in 2017 due to a large number of patients suffering from AIDS at hospitals across the globe. Moreover, an increase in funding for research and development for new diagnostic tests that are more sensitive and specific than conventional methods is anticipated to boost product demand over the forecast period.
The home care setting segment is expected to witness lucrative growth over the forecast period owing to an increase in prevalence rates of HIV among individuals aged 60 years or above as well as people who have sex with men. In addition, increasing awareness about these types of tests being available directly at consumers¢â‚¬â„¢ homes will further boost industry growth during this period.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, availability of advanced technologies and high prevalence rate are some factors responsible for its growth. Moreover, increasing government initiatives to control the spread of HIV is also expected to drive this regional market over the forecast period. For instance, in December 2016, CDC launched a free online tool called Quick Test that can be used by people living with HIV to test their viral load which helps them take informed decisions regarding antiretroviral therapy (ART) and other interventions such as condom use or PrEP medication.
Growth Factors:
- Increasing incidence of HIV/AIDS: The global incidence of HIV is increasing at an alarming rate. This is primarily because of the lack of awareness about the disease and its prevention methods. According to a study by WHO, around 36 million people were living with HIV in 2015, and 2 million people were infected with the virus that year. The number is only expected to grow in the coming years, making it essential for healthcare providers to adopt POC testing as a means to diagnose patients early on and provide them with appropriate treatment options.
- Government initiatives for POC testing: Governments across the globe are recognizing the importance of POC testing and are taking steps to promote its adoption among healthcare providers. For instance, in 2016, India's Ministry of Health & Family Welfare launched a program called "Test & Treat" which aims to provide free-of-cost POC tests for all Indians who need them. Such government initiatives will play a major role in driving growth for the HIV Point-of-care Testing market in upcoming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
HIV Point-of-care Testing Market Research Report
By Type
Testing Equipment, Testing Reagent
By Application
Hospitals, Clinics, Home Care Setting
By Companies
Abbott, BD, Biomerieux, Adaltis, Roche, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
186
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global HIV Point-of-care Testing Market Report Segments:
The global HIV Point-of-care Testing market is segmented on the basis of:
Types
Testing Equipment, Testing Reagent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Care Setting
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- BD
- Biomerieux
- Adaltis
- Roche
- Abbott
Highlights of The HIV Point-of-care Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Testing Equipment
- Testing Reagent
- By Application:
- Hospitals
- Clinics
- Home Care Setting
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HIV Point-of-care Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HIV Point-of-care Testing is a simple, quick way to test for HIV. It's available at many health clinics and hospitals around the world. You can also get it done at some pharmacies.
Some of the major companies in the hiv point-of-care testing market are Abbott, BD, Biomerieux, Adaltis, Roche, Abbott.
The hiv point-of-care testing market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HIV Point-of-care Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HIV Point-of-care Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HIV Point-of-care Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HIV Point-of-care Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HIV Point-of-care Testing Market Size & Forecast, 2018-2028
4.5.1 HIV Point-of-care Testing Market Size and Y-o-Y Growth
4.5.2 HIV Point-of-care Testing Market Absolute $ Opportunity
Chapter 5 Global HIV Point-of-care Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 HIV Point-of-care Testing Market Size Forecast by Type
5.2.1 Testing Equipment
5.2.2 Testing Reagent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global HIV Point-of-care Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 HIV Point-of-care Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Home Care Setting
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HIV Point-of-care Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HIV Point-of-care Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America HIV Point-of-care Testing Analysis and Forecast
9.1 Introduction
9.2 North America HIV Point-of-care Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America HIV Point-of-care Testing Market Size Forecast by Type
9.6.1 Testing Equipment
9.6.2 Testing Reagent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America HIV Point-of-care Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Home Care Setting
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe HIV Point-of-care Testing Analysis and Forecast
10.1 Introduction
10.2 Europe HIV Point-of-care Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe HIV Point-of-care Testing Market Size Forecast by Type
10.6.1 Testing Equipment
10.6.2 Testing Reagent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe HIV Point-of-care Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Home Care Setting
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific HIV Point-of-care Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific HIV Point-of-care Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific HIV Point-of-care Testing Market Size Forecast by Type
11.6.1 Testing Equipment
11.6.2 Testing Reagent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific HIV Point-of-care Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Home Care Setting
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America HIV Point-of-care Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America HIV Point-of-care Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America HIV Point-of-care Testing Market Size Forecast by Type
12.6.1 Testing Equipment
12.6.2 Testing Reagent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America HIV Point-of-care Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Home Care Setting
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) HIV Point-of-care Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) HIV Point-of-care Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) HIV Point-of-care Testing Market Size Forecast by Type
13.6.1 Testing Equipment
13.6.2 Testing Reagent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) HIV Point-of-care Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Home Care Setting
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HIV Point-of-care Testing Market: Competitive Dashboard
14.2 Global HIV Point-of-care Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 BD
14.3.3 Biomerieux
14.3.4 Adaltis
14.3.5 Roche
14.3.6 Abbott
